NCT05397535Completed
Baduanjin Lower Elevated Blood PreSsure Study
Traditional Exercise as Convenient Approach to Improve Health 1-Baduanjin Lower Elevated Blood PreSsure Study
Source: ClinicalTrials.gov · Last updated 10 Sept 2025
Brief summary (registry, in English)
The aim of this study is to evaluate the effects of Baduanjin on blood pressure in individuals with high normal blood pressure (SBP 130-139 mmHg, and/or DBP 85-89 mmHg), as well as on glucose and lipid metabolism, quality of life, psychology, exercise, immune inflammation, endothelial function, and arterial stiffness.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 216 (actual)
- First submitted
- 20 May 2022
- Start date
- 5 Jun 2022
- Primary completion date
- 4 Jul 2024
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Diseases
- High blood pressure
- NCT number
- NCT05397535
What you commit to
- Study type: Interventional
- Participants enrolled: 216
- From 5 Jun 2022 to the primary completion date, 4 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having taken antihypertensive drugs or immunoregulators within 2 weeks
- A long-term need for antihypertensive drugs or immunomoregulators
- Currently taking regular exercise (at least 30 minutes of moderate-intensity exercise at least three times a week)
Other illness
- Diagnosis of hypertension (SBP≥140 mmHg, and/or DBP ≥90mmHg）
- History of cardiovascular diseases, such as coronary heart disease, heart failure, stroke, and peripheral vascular disease
- Diagnosis of chronic kidney disease, primary aldosteronism, Cushing's syndrome, or pheochromocytoma
- Newly diagnosed cancer or cancer metastasis within 5 years
- History of autoimmune disease
- Unable to maintain moderate intensity exercise due to illness or other reasons
- Allergic to sports bracelets
- Other factors that may affect the follow-up, such as alcohol or substance abuse in the last 12 months, planing to live out of town for a long time, or diagnosis of dementia or cognitive impairment which indicates incapability of completing the study
Other
- Pregnant, breastfeeding, or planning to become pregnant within the next 1 year
- Having participated or been participating in other clinical trials within the last 3 months
- Unable to use smartphones
- Unable to accurately measure blood pressure using the sphygmomanometer provided by the study due to a too large or too small arm circumference
Who the study is looking for
- Age 40 years or older;
- Systolic blood pressure (SBP) \<140 mmHg and diastolic blood pressure (DBP) \<90 mmHg
- SBP 130-139 mmHg, and/or DBP 85-89 mmHg
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fuwai Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.